Lauren E. Haydu, PhD MPH

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	78709	47598
h-endeksi	68	59
i10-endeksi	150	141

10000

5000

2500

7500

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024500 1038 1188 1189 1422 1467 1404 1416 1350 1343 1423 1707 1838 1973 2202 2512 2790 3529 5493 7696 8997 9354 8688 7323

Genel erişim

Tümünü görüntüle

91 makale

6 makale*

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

John F ThompsonMelanoma Institute Australiamelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred Hospitalsswahs.nsw.gov.au üzerinde doğrulanmış e-posta adresine sahip
Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore Hospitalsydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Alexander M MenziesMelanoma Institute Australia, The University of Sydney, Royal North Shore Hospitalsydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Richard KeffordMacquarie Universitymq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Robyn SawMelanoma Institute Australiamelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
A SpillaneUniversity of Sydneymelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
Jonathan StretchMelanoma Institute Australiamelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
Jeff GershenwaldThe University of Texas MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Graham MannCollege of Health and Medicine, Australian National Universityanu.edu.au üzerinde doğrulanmış e-posta adresine sahip
Gerald FogartyICON Cancer Centre, Revesby, Sydney NSW.Icon.Team üzerinde doğrulanmış e-posta adresine sahip
James S WilmottMelanoma Institute Australia, The University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Alexander J. Lazar MD/PhDProfessor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer Ctrmdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Carlino Matteo SMelanoma Institute Australia; Westmead Hospitalsydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Jennifer Leigh McQuadeInstructor of Melanoma Medical Oncology, UT MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Rajmohan MuraliMemorial Sloan Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip
Serigne LoMelanoma Institute Australia, The University of Sydneymelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
Peter Herseysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Helen RizosMacquarie Universitymq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Patrick HwuPresident and CEO, The Moffitt Cancer Center, Tampa, FLmoffitt.org üzerinde doğrulanmış e-posta adresine sahip

Takip et

Lauren E. Haydu, PhD MPH

Mayo Clinic

mayo.edu üzerinde doğrulanmış e-posta adresine sahip

Biostatistician


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Initial sequencing and analysis of the human genome US DOE Joint Genome Institute: Hawkins Trevor 4 Branscomb Elbert 4 Predki ... Nature 409 (6822), 860-921, 2001	25087	2001
Finishing the euchromatic sequence of the human genome International Human Genome Sequencing Consortium Nature 431 (7011), 931-945, 2004	5345	2004
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	4832	2018
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018	4231	2018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018	2911	2018
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015	2822	2015
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018	2727	2018
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017	2382	2017
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	2337	2018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018	2188	2018
B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020	1953	2020
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018	1772	2018
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma GV Long, AM Menzies, AM Nagrial, LE Haydu, AL Hamilton, GJ Mann, ... Journal of Clinical Oncology 29 (10), 1239-1246, 2011	1310	2011
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016	977	2016
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018	895	2018
Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018	802	2018
Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018	770	2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018	760	2018
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas T Palomero, L Couronné, H Khiabanian, MY Kim, A Ambesi-Impiombato, ... Nature genetics 46 (2), 166-170, 2014	688	2014
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ... Cell systems 6 (3), 271-281. e7, 2018	686	2018

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar